Athira Pharma Inc

ATHA

Company Profile

  • Business description

    Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.

  • Contact

    18706 North Creek Parkway
    Suite 104
    BothellWA98011
    USA

    T: +1 425 620-8501

    E: [email protected]

    https://www.athira.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    26

Stocks News & Analysis

stocks

How I lost all my savings through a poor investment decision

With first timers at risk of poor investment decisions and an interest in speculative stocks, I explore my biggest investing mistake.
stocks

Our view of Nvidia / OpenAI deal

Big AI dreams as firms announce a strategic partnership.
stocks

Chart of the Week: Morningstar’s forecast for CSL’s future

We see gross margin expansion on efficiencies and limited tariff impact

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,063.4033.900.38%
CAC 407,779.6647.79-0.61%
DAX 4023,521.42145.39-0.61%
Dow JONES (US)46,041.3679.92-0.17%
FTSE 1009,209.5040.93-0.44%
HKSE26,484.6833.97-0.13%
NASDAQ22,407.6590.21-0.40%
Nikkei 22545,754.93124.620.27%
NZX 50 Index13,153.7927.52-0.21%
S&P 5006,609.2728.70-0.43%
S&P/ASX 2008,773.0035.100.40%
SSE Composite Index3,853.300.34-0.01%

Market Movers